IHI CORP (IHICY)
(Delayed Data from OTC)
$27.68 USD
0.00 (0.00%)
Updated Jul 31, 2025 12:49 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IHICY 27.68 0.00(0.00%)
Will IHICY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IHICY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IHICY
Beat the Market the Zacks Way: Humacyte, Starbucks, Oracle in Focus
Amcor Boosts PCR Capabilities With Latest Investment in Kentucky
IHICY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Recent Price Trend in IHI CORP (IHICY) is Your Friend, Here's Why
Is Intellicheck Mobilisa (IDN) Stock Outpacing Its Industrial Products Peers This Year?
Flowserve (FLS) Surges 6.8%: Is This an Indication of Further Gains?
Other News for IHICY
Fidelity International Small Cap Opportunities Fund Q2 2025 Commentary
Fidelity International Small Cap Opportunities Fund Q1 2025 Review